Table 4.
Variables | No of participants | OR (95% CI) | P value |
Age | |||
≥60 years | 107 | ||
G0–1 | 37 | Ref. | |
G2 | 45 | 1.813 (0.668 to 4.919) | 0.632 |
G≥3 | 25 | 2.848 (0.937 to 8.659) | 0.87 |
<60 years | 1267 | ||
G0–1 | 556 | Ref. | |
G2 | 517 | 1.566 (1.134 to 2.163) | 0.006 |
G≥3 | 194 | 1.989 (1.324 to 2.988) | 0.001 |
Elevated GGT | |||
Yes | 451 | ||
G0–1 | 141 | Ref. | |
G2 | 191 | 1.919 (1.077 to 3.420) | 0.027 |
G≥3 | 119 | 2.420 (1.304 to 4.490) | 0.005 |
No | 923 | ||
G0–1 | 452 | Ref. | |
G2 | 371 | 1.458 (1.011 to 2.105) | 0.019 |
G≥3 | 100 | 1.880 (1.108 to 3.190) | 0.044 |
AILDs | |||
Yes | 43 | ||
G0–1 | 9 | Ref. | |
G2 | 13 | 1.714 (0.294 to 9.999) | 0.549 |
G≥3 | 21 | 1.818 (0.357 to 9.272) | 0.472 |
No | 1331 | ||
G0–1 | 584 | Ref | |
G2 | 549 | 1.587 (1.161 to 2.167) | 0.004 |
G≥3 | 198 | 1.959 (1.313 to 2.923) | 0.001 |
AILDs, autoimmune liver diseases; GGT, gamma-glutamyl-transferase.